Stay updated on Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis

Sign up to get notified when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record of a Phase 2 clinical trial evaluating the safety and efficacy of KZR-616 in patients with active Polymyositis or Dermatomyositis.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:01.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as age, BMI, and specific diagnostic criteria for DM or PM, along with examples of inclusion and exclusion criteria.
    Difference
    33%
    Check dated 2024-05-22T20:32:13.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:01:47.000Z thumbnail image

Stay in the know with updates to Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.